SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| BRASIER BARBARA L | Director | 2026-07-01 | Grant/award | 237 | $55K |
| Bacon Debra | EVP, Medicaid | 2026-07-01 | Tax withholding | 183 | $43K |
| GROHOWSKI LEO P | Director | 2026-07-01 | Grant/award | 237 | $55K |
| Lockhart Stephen H | Director | 2026-07-01 | Grant/award | 237 | $55K |
| ORLANDO STEVEN J | Director | 2026-07-01 | Grant/award | 237 | $55K |
| ROMNEY RONNA | Director | 2026-07-01 | Grant/award | 237 | $55K |
| SOISTMAN FRANCIS S JR | Director | 2026-07-01 | Grant/award | 237 | $55K |
| Schapiro Richard M | Director | 2026-07-01 | Grant/award | 237 | $55K |
| WOLF DALE B | Director | 2026-07-01 | Grant/award | 237 | $55K |
| ZORETIC RICHARD C | Director | 2026-07-01 | Grant/award | 237 | $55K |
| Bacon Debra | EVP, Medicaid | 2026-06-30 | Grant/award | 23 | $3K |
| Barlow Jeff D. | Chief Legal Officer | 2026-06-30 | Grant/award | 138 | $20K |
| WOYS JAMES | Chief Operating Officer | 2026-06-30 | Grant/award | 144 | $21K |
| HEBERT MAURICE | Chief Accounting Officer | 2026-05-14 | Open-market sell | 600 | $115K |
| Barlow Jeff D. | Chief Legal Officer | 2026-05-11 | Open-market sell | 17811 | $3.3M |
| SOISTMAN FRANCIS S JR | Director | 2026-05-06 | Grant/award | 170 | $34K |
| BRASIER BARBARA L | Director | 2026-04-01 | Grant/award | 405 | $55K |
| GROHOWSKI LEO P | Director | 2026-04-01 | Grant/award | 405 | $55K |
| Lockhart Stephen H | Director | 2026-04-01 | Grant/award | 405 | $55K |
| ORLANDO STEVEN J | Director | 2026-04-01 | Grant/award | 405 | $55K |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
Risk deteriorated pervasively across six or more distinct themes, with no meaningful offsets. The OBBBA's quantified 1.2M-member enrollment reduction, a tightened credit covenant with a reduced 1.75:1.0 Interest Coverage Ratio threshold, and a medical care ratio spike to 91.7% (earnings sensitivity now $6.20/share per point) collectively signal acute financial stress. Compounding pressures include realized subsidy expiration, expanded False Claims Act exposure, a 17% goodwill increase with broadened impairment triggers, and escalating AI/cybersecurity obligations — a broad-based deterioration with no theme moving in the company's favor.
9 company-specific · 4 common-mode
Medical care ratio deteriorated from 89.1% to 91.7%; earnings sensitivity increased from $5.24 to $6.20 per share per percentage point, indicating worsened profitability vulnerability.
If we fail to accurately predict and effectively manage our medical care costs, our operating results could be materially and adversely affected. Our profitability depends to a significant degree on…
Escalated risk: added evidence of actual medical cost spikes outpacing rates, retroactive recoupment risk, and explicit acknowledgment of inability to predict future expenses.
RISKS RELATED TO OUR BUSINESS The Medicaid rates paid to us by states may be insufficient to cover our rising medical care costs. Our premium revenues consist of fixed monthly payments per member…
Subsidy expiration now occurred (end of 2025); uncertainty about renewal added. Market participation reduced (Michigan, Wisconsin added to exclusion list). Risk escalated from prospective to realized.
Our Marketplace business has been volatile and unpredictable, and has been subject to annual programmatic changes that are difficult to price for actuarially. We offer Marketplace plans in many of…
New credit agreement with tightened covenants and temporary reduction in Interest Coverage Ratio threshold to 1.75:1.0 signals financial stress and increased default risk.
Restrictive covenants in our debt instruments may restrict our ability to pursue our business strategies or have other adverse consequences. We are party to a credit agreement dated as of November…
Added explicit "recoupment" language and clarified states can retroactively recoup "final" payments, escalating revenue uncertainty risk.
Our Medicaid premium revenues could be adversely impacted by retroactive adjustments or recoupments, or states’ delays in implementing rate changes. The complexity of some of our Medicaid contract…
Added explicit risk of "unexpected emergence of liabilities" in acquired entities and reference to "embedded earnings" realization—both escalate integration risk beyond prior boilerplate language.
We may be unable to successfully integrate our acquisitions or realize the anticipated benefits of such acquisitions, including the full realization of our embedded earnings. Our growth strategy…
New disclosure of provider directory inaccuracy risks, including fines, sanctions, and lawsuits from natural turnover in physician practices.
If we are unable to deliver quality care, and maintain good relations with the physicians, hospitals, and other providers with whom we contract, or if we are unable to enter into cost-effective…
Goodwill increased 17% to $1.96B; impairment triggers expanded to include market cap declines and regulatory changes, broadening impairment risk.
An impairment charge with respect to our recorded goodwill, or our finite-lived intangible assets, could have a material impact on our financial results. As of December 31, 2025, the carrying amount…
Added language that False Claims Act suits may proceed if claimant was out of compliance with program requirements, and expanded discussion of Civil Investigative Demands costs. Materially broadens litigation exposure.
We are subject to extensive fraud and abuse laws that may give rise to lawsuits and claims against us, the outcome of which may have a material adverse effect on our business, financial condition…
New disclosure of OBBBA's material impact: 15-20% enrollment reduction (1.2M members), provider payment caps, and APTC elimination create quantified, significant revenue and membership risk.
Any changes to the laws and regulations governing our business, or the interpretation and enforcement of those laws or regulations implemented by the Trump administration, could require us to modify…
New specific regulatory risks added: California CCPA automated decision-making rules (Jan 2026), 17 new CA AI laws, state "high-risk" AI safeguards, and federal preemption litigation threat. Escalates from general uncertainty to concrete compliance obligations.
We may not be successful in our AI administrative and operational initiatives, which could adversely affect our business or reputation. As part of our operating efficiencies, we are making…
Revised disclosure escalates cybersecurity risk: adds AI-related threats, acquisition vulnerabilities, customer patch-failure exposure, and contractual liquidated damages liability.
We and our third-party service providers are exposed to cybersecurity risks, which may result in operational impact, increased costs, exposure to significant legal liability, reputational harm, loss…
Added explicit dependency on cloud providers and AI capabilities as integral to operations, expanding technology risk surface and introducing new third-party vulnerabilities.
Our business depends on our information and medical management systems, and our inability to effectively integrate, manage, update, and keep secure our information and medical management systems…
Molina Healthcare issued a press release on July 22, 2026 reporting second quarter 2026 financial results (GAAP EPS of $1.19, adjusted EPS of $1.51) and increased full-year 2026 earnings guidance to at least $5.25 per diluted share. The disclosure includes detailed financial statements, segment data, and management commentary on operational performance. This is a standard quarterly earnings release filed under Item 2.02, materially affecting investor assessment of the company's financial condition and performance.
View raw filing on EDGAR →Molina Healthcare announced that the Illinois Department of Healthcare and Family Services intends to award a HealthChoice Illinois Medicaid Managed Care program contract to its Illinois subsidiary. This is a material contract award that would affect the registrant's revenue and business operations, but it does not fit neatly into the standard M&A, earnings, or executive event categories. The disclosure is made under Regulation FD (Item 7.01), indicating it is material information being disclosed to investors.
View raw filing on EDGAR →